Exactech acquired Muvr Labs, provider of intelligent patient wearables and digital communication tools. The latest addition to Exactech’s Active Intelligence® platform of technologies, the Muvr portfolio is designed to help surgeons engage with joint replacement patients throughout the journey of care.
Pilot launch of Muvr technology is slated for early 2021, with full release by year end. Exactech plans to develop the technology to support shoulder and ankle replacement surgery.
The platform includes patient wearables, mobile device applications and chatbot texting, Wireless sensors measure range of motion, not just steps taken. The self-calibrating design allows the patient to manage the wearable independently without additional in-person office visits, and requires minimal intervention by the healthcare team.
Muvr’s tablet application offers a surgeon dashboard to easily identify at-risk patients and connect remotely for follow-up. The surgeon/patient chatbot is a customizable software application that automatically conducts text conversations to provide patient reminders and respond to patients’ most common questions. The Muvr technology reduces the surgical team’s workload while collecting pain scores, exercise adherence, mobility metrics and survey information.
“We are incredibly excited to join efforts with the team at Muvr to transform the relationship between patients and surgeons through this comprehensive care management platform,” said Darin Johnson, Exactech Chief Executive Officer. “This acquisition demonstrates our continued commitment to delivering personalized, data-driven solutions to improve patient outcomes.”